GD
LinkedIn

Gregory Daniel

Vice President, Head of Public Policy Innovation, Evidence, and Engagement

Washington DC-Baltimore Area · 1 connection

Eli Lilly and Company

Not on Unlinked · Imported profile. Is this you? Claim it

About

Executive leader in health policy, pharmaceutical & medical device policy, and real-world evidence (RWE) development with leadership experience in the CRO/payer, academic, DC-based think-tank and life sciences corporate environments. Dedicated to advancing policies that encourage and support high-value breakthrough innovation that meets patient unmet needs and, at the same time, enable equal and affordable access to such treatments. Global Head of Public Policy at Eli Lilly and Company; Editor-in-Chief, Therapeutic Innovation and Regulatory Science (TIRS) peer-reviewed scientific journal; and Past-President, Board of Directors, Innovation in Value Initiative (IVI). Policy expertise: ♦ Drug and medical device payment and coverage policy ♦ Value-based healthcare reforms ♦ Regulatory science, drug/device development policy ♦ Improving the use of real-world evidence (RWE) to support regulatory and payer decisions. Data and research expertise: ♦ RWE, health economics and outcomes research, comparative effectiveness research, and drug safety and pharmacoepidemiology ♦ Biostatistics and epidemiology ♦ Leveraging real world data from health insurance claims and EHRs to support research tha

Experience

Vice President, Head of Public Policy Innovation, Evidence, and EngagementEli Lilly and Company
Jan 2024
Vice President, Head of Global Public PolicyEli Lilly and Company
Mar 2023 to Jan 2024
Associate VP & Head of Global Public PolicyEli Lilly and Company
May 2021 to Mar 2023
Head, U.S. Healthcare PolicyEdwards Lifesciences
Sep 2019 to May 2021
Deputy Center Director and Clinical Professor, Duke-Margolis Center for Health PolicyDuke University
Jan 2016 to Aug 2019
Fellow and Managing Director, Center for Health PolicyThe Brookings Institution
Nov 2011 to Jan 2016
Vice President, Government & Academic ResearchCarelon
Jun 2010 to Nov 2011
Director, Research OperationsCarelon
May 2006 to Jun 2010
Outcomes Research ManagerCarelon
Sep 2002 to May 2006

Education

University of Arizona
Doctor of Philosophy Pharmaceutical Economics Policy and Outcomes
2004 to 2008
The Ohio State University
Master of Public Health Biostatistics
2000 to 2002
The Ohio State University
Master of Science Pharmaceutcial Sciences
2000 to 2002
The Ohio State University
Bachelor of Science Pharmacy
1995 to 2000